Pacific Biosciences Other Assets Over Time
| PACB Stock | USD 1.85 0.05 2.78% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pacific Biosciences Performance and Pacific Biosciences Correlation. Pacific |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 0.64 | Quarterly Revenue Growth (0.28) | Return On Assets (0.11) | Return On Equity (0.65) |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Assets Analysis
Compare Pacific Biosciences and related stocks such as Twist Bioscience Corp, Intellia Therapeutics, and Crispr Therapeutics Other Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TWST | 536 K | 536 K | 536 K | 536 K | 536 K | 536 K | 896 K | 5.9 M | 4.4 M | 3.4 M | 49.9 M | (1000) | (1000) | (1.1 K) | (1.1 K) |
| NTLA | 256 K | 256 K | 256 K | 256 K | 256 K | 1.8 M | 7 M | 6.1 M | 5.3 M | 2.9 M | 4.7 M | 4.8 M | 15.7 M | 18.1 M | 19 M |
| CRSP | 50 K | 50 K | 50 K | 50 K | 50 K | 801 K | 3.3 M | 3.8 M | 3.8 M | 6.1 M | 18.1 M | 22.2 M | 16.3 M | 18.7 M | 19.7 M |
| EDIT | 340 K | 340 K | 340 K | 340 K | 360 K | 2.2 M | 1.6 M | 1.6 M | 1.7 M | 1.7 M | 4.7 M | 6.8 M | 5.3 M | 6 M | 6.3 M |
Pacific Biosciences and related stocks such as Twist Bioscience Corp, Intellia Therapeutics, and Crispr Therapeutics Other Assets description
My Equities
My Current Equities and Potential Positions
| Pacific Biosciences of | PACB |
| Classification | Measuring and Control Equipment |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.85
Check out Pacific Biosciences Performance and Pacific Biosciences Correlation. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Pacific Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.